Imaging in solution of (Lys)16-containing bifunctional synthetic peptide/DNA nanoparticles for gene delivery

被引:7
作者
Collins, L
Kaszuba, M
Fabre, JW
机构
[1] Rayne Inst, Dept Clin Sci, London SE5 9NU, England
[2] Malvern Instruments Ltd, Malvern WR14 1XZ, Worcs, England
来源
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | 2004年 / 1672卷 / 01期
基金
英国生物技术与生命科学研究理事会;
关键词
gene therapy; vector/DNA nanoparticle; synthetic peptide; DNA vector; polylysine; fluid particle image analyser;
D O I
10.1016/j.bbagen.2004.02.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The physical properties of non-viral vector/DNA nanoparticles in physiological aqueous solution are poorly understood. A Fluid Particle image Analyser (FPIA), normally used for analysis of industrial and environmental fluids, was used to visualise individual (Lys)(16)-containing peptide/DNA particles. Eight (Lys)(16)-containing synthetic peptides were used to generate peptide/DNA particles at a constant + to - charge ratio of 2.8:1 with 10 mug/ml of plasmid DNA in phosphate buffered saline. Dynamic Light Scattering (DLS) and gene delivery studies were also performed. We present the first images of non-viral vector/DNA nanoparticles in physiological aqueous solution, together with precise measurements of individual particle size and shape in solution and, for the first time, an accurate measure of particle number. Particle size and shape, particle number, and efficiency for gene delivery varied markedly with different peptides. Under standard conditions for in vitro gene delivery, we estimate similar to60 peptide/DNA nanoparticles per target cell, each containing similar to70,000 plasmids. This novel capacity to image individual vector/DNA nanoparticles in solution and to count them accurately will enable a more precise assessment of non-viral gene delivery systems, and a more quantitative interpretation of gene delivery experiments. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:12 / 20
页数:9
相关论文
共 27 条
[1]
[Anonymous], 1996, 13321 ISO
[2]
The nuclear pore complex is involved in nuclear transfer of plasmid DNA condensed with an oligolysine-RGD peptide containing nuclear localisation properties [J].
Colin, M ;
Moritz, S ;
Fontanges, P ;
Kornprobst, M ;
Delouis, C ;
Keller, M ;
Miller, AD ;
Capeau, J ;
Coutelle, C ;
Brahimi-Horn, MC .
GENE THERAPY, 2001, 8 (21) :1643-1653
[3]
Tissue-binding properties of a synthetic peptide DNA vector targeted to cell membrane integrins - A possible universal nonviral vector for organ and tissue transplantation [J].
Collins, L ;
Gustafsson, K ;
Fabre, JW .
TRANSPLANTATION, 2000, 69 (06) :1041-1050
[4]
In vitro investigation of factors important for the delivery of an integrin-targeted nonviral DNA vector in organ transplantation [J].
Collins, L ;
Sawyer, GJ ;
Zhang, XH ;
Gustafsson, K ;
Fabre, JW .
TRANSPLANTATION, 2000, 69 (06) :1168-1176
[5]
CONNOR SD, 2003, NATURE, V6, P37
[6]
STRUCTURAL-ANALYSIS OF INTEGRIN RECOGNITION AND THE INHIBITION OF INTEGRIN-MEDIATED CELL FUNCTIONS BY NOVEL NONPEPTIDIC SURROGATES OF THE ARG-GLY-ASP SEQUENCE [J].
GREENSPOON, N ;
HERSHKOVIZ, R ;
ALON, R ;
VARON, D ;
SHENKMAN, B ;
MARX, G ;
FEDERMAN, S ;
KAPUSTINA, G ;
LIDER, O .
BIOCHEMISTRY, 1993, 32 (04) :1001-1008
[7]
MULTIPLE BETA-1-CHAIN INTEGRINS ARE RECEPTORS FOR INVASIN, A PROTEIN THAT PROMOTES BACTERIAL PENETRATION INTO MAMMALIAN-CELLS [J].
ISBERG, RR ;
LEONG, JM .
CELL, 1990, 60 (05) :861-871
[8]
JOSLIN G, 1991, J BIOL CHEM, V266, P11282
[9]
Viral vectors for gene therapy: the art of turning infectious agents into vehicles of therapeutics [J].
Kay, MA ;
Glorioso, JC ;
Naldini, L .
NATURE MEDICINE, 2001, 7 (01) :33-40
[10]
LabatMoleur F, 1996, GENE THER, V3, P1010